These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 29540332)
61. [Immediate and delayed hypersensitivity reactions to iodinated radiographic contrast agents: an update]. Khachman D; Gandia P; Sallerin F; Mailly N Therapie; 2009; 64(5):331-9. PubMed ID: 19863909 [TBL] [Abstract][Full Text] [Related]
62. MRI contrast agents: basic chemistry and safety. Hao D; Ai T; Goerner F; Hu X; Runge VM; Tweedle M J Magn Reson Imaging; 2012 Nov; 36(5):1060-71. PubMed ID: 23090917 [TBL] [Abstract][Full Text] [Related]
63. 'Gadolinium' as an alternative to iodinated contrast media for X-ray angiography in patients with severe allergy. Ose K; Doue T; Zen K; Hadase M; Sawada T; Azuma A; Matsubara H Circ J; 2005 Apr; 69(4):507-9. PubMed ID: 15791052 [TBL] [Abstract][Full Text] [Related]
64. Gadolinium contrast agents - are they really safe? Malikova H; Holesta M J Vasc Access; 2017 Mar; 18(Suppl. 2):1-7. PubMed ID: 28362042 [TBL] [Abstract][Full Text] [Related]
65. Assessment of first-time and repeated acute adverse reactions to gadolinium-based contrast agents in MRI: A retrospective study. Fukushima Y; Ozaki D; Taketomi-Takahashi A; Hirasawa H; Ujita K; Suto T; Tsushima Y Eur J Radiol; 2024 Jul; 176():111504. PubMed ID: 38761445 [TBL] [Abstract][Full Text] [Related]
67. First case report of acute generalized exanthematous pustulosis (AGEP) caused by gadolinium confirmed by patch testing. Bordel Gómez MT; Martín García C; Meseguer Yebra C; Zafra Cobo MI; Cardeñoso Álvarez ME; Sánchez Estella J Contact Dermatitis; 2018 Feb; 78(2):166-168. PubMed ID: 29341190 [No Abstract] [Full Text] [Related]
68. Use of gadolinium chelate to confirm epidural needle placement in patients with an iodinated contrast reaction. Shetty SK; Nelson EN; Lawrimore TM; Palmer WE Skeletal Radiol; 2007 Apr; 36(4):301-7. PubMed ID: 17187289 [TBL] [Abstract][Full Text] [Related]
69. Contrast media and cutaneous reactions. Part 1. Immediate hypersensitivity reactions to contrast media and gadolinium deposition. Tasker F; Fleming H; McNeill G; Creamer D; Walsh S Clin Exp Dermatol; 2019 Dec; 44(8):839-843. PubMed ID: 31112335 [TBL] [Abstract][Full Text] [Related]
70. Hypersensitivity reactions and contrast medium injection: are they always related? Böhm I; Alfke H; Klose KJ Eur J Radiol; 2011 Nov; 80(2):368-72. PubMed ID: 21251786 [TBL] [Abstract][Full Text] [Related]
71. Trends and developments in MRI contrast agent research. Cavagna FM; Daprà M; Castelli PM; Maggioni F; Kirchin MA Eur Radiol; 1997; 7 Suppl 5():222-4. PubMed ID: 9370547 [TBL] [Abstract][Full Text] [Related]
72. Intraindividual Analysis of Signal Intensity Changes in the Dentate Nucleus After Consecutive Serial Applications of Linear and Macrocyclic Gadolinium-Based Contrast Agents. Radbruch A; Weberling LD; Kieslich PJ; Hepp J; Kickingereder P; Wick W; Schlemmer HP; Bendszus M Invest Radiol; 2016 Nov; 51(11):683-690. PubMed ID: 27495187 [TBL] [Abstract][Full Text] [Related]
73. Safety of gadobutrol in more than 1,000 pediatric patients: subanalysis of the GARDIAN study, a global multicenter prospective non-interventional study. Glutig K; Bhargava R; Hahn G; Hirsch W; Kunze C; Mentzel HJ; Schaefer JF; Willinek W; Palkowitsch P; Pediatr Radiol; 2016 Aug; 46(9):1317-23. PubMed ID: 27041276 [TBL] [Abstract][Full Text] [Related]
74. Extracellular gadolinium-based contrast media: an overview. Bellin MF; Van Der Molen AJ Eur J Radiol; 2008 May; 66(2):160-7. PubMed ID: 18358659 [TBL] [Abstract][Full Text] [Related]
75. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance]. Campos A; Aznar L; Alamar R; Castelló JV Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023 [No Abstract] [Full Text] [Related]
76. Gd-based Contrast Enhancement of the Perivascular Spaces in the Basal Ganglia. Naganawa S; Nakane T; Kawai H; Taoka T Magn Reson Med Sci; 2017 Jan; 16(1):61-65. PubMed ID: 27430361 [TBL] [Abstract][Full Text] [Related]
77. Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes. Kane GC; Stanson AW; Kalnicka D; Rosenthal DW; Lee CU; Textor SC; Garovic VD Nephrol Dial Transplant; 2008 Apr; 23(4):1233-40. PubMed ID: 18256017 [TBL] [Abstract][Full Text] [Related]
78. Love bite: An unusual differential diagnosis of an adverse reaction following the application of a gadolinium-based contrast agent. Boehm IB; Sah BR Magn Reson Imaging; 2022 Apr; 87():86-87. PubMed ID: 34986392 [No Abstract] [Full Text] [Related]
79. Equilibrium-phase MR angiography: Comparison of unspecific extracellular and protein-binding gadolinium-based contrast media with respect to image quality. Erb-Eigner K; Taupitz M; Asbach P Contrast Media Mol Imaging; 2016; 11(1):71-6. PubMed ID: 26265484 [TBL] [Abstract][Full Text] [Related]
80. Gadolinium detection via in vivo prompt gamma neutron activation analysis following gadolinium-based contrast agent injection: a pilot study in 10 human participants. Gräfe JL; McNeill FE; Noseworthy MD; Chettle DR Physiol Meas; 2014 Sep; 35(9):1861-72. PubMed ID: 25154504 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]